Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Sagnik Bhattacharyya

King’s College London

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Psychiatry

100%

Neuropsychology

70%

Psychosis

90%

Endocannabinoid

50%

Neuropharmacology

50%

Mental Illness

30%

Neuroscience

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles19

Cannabidiol as a treatment for patients who are clinically at high risk of developing psychosis: learnings from the CANTOP-RCT

Article Link

Year:

2025

Parkinson’s disease psychosis associated with accelerated multidomain cognitive decline

Article Link

Year:

2024

A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses

Article Link

Year:

2024

Cannabidiol for behavior symptoms in Alzheimer's disease (CANBiS-AD)

Article Link

Year:

2024

Adverse events caused by cannabinoids in middle aged and older adults for all indications

Article Link

Year:

2024

Effects of cannabidiol on symptoms in people at clinical high risk for psychosis

Article Link

Year:

2024

Functional and connectivity correlates associated with Parkinson's disease psychosis

Article Link

Year:

2024

Cognitive and executive impairments in Parkinson’s disease psychosis: a Bayesian meta-analysis

Article Link

Year:

2023

Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis

Article Link

Year:

2023

Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis

Article Link

Year:

2023

Stressful life events and relapse of psychosis

Article Link

Year:

2023

Grey matter volume loss in Parkinson’s Disease Psychosis and its relationship with serotonergic gene expression: A meta-analysis

Article Link

Year:

2023

Association between stressful life events and psychosis relapse

Article Link

Year:

2023

Questioning the role of palmitoylethanolamide in psychosis

Article Link

Year:

2023

Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk

Article Link

Year:

2023

Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol

Article Link

Year:

2023

Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression

Article Link

Year:

2022

Cannabinoids in psychiatry

Article Link

Year:

2022

The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System

Article Link

Year:

2022

Collaborators15

Marco Colizzi

University of Udine

ITALY

K Ray Chaudhuri

King’s College London

UNITED KINGDOM

Fernando Zelaya

King’s College London

UNITED KINGDOM

Jorn Lotsch

Professor (Full)

Goethe University Frankfurt

GERMANY

Charlotte Pretzsch

King’s College London

UNITED KINGDOM

Daniel Martins

King’s College London

UNITED KINGDOM

Latha Velayudhan

King’s College London

UNITED KINGDOM

Alison Yung

The University of Manchester

UNITED KINGDOM

robin murray

King’s College London

UNITED KINGDOM

Dominic ffytche

King’s College London

UNITED KINGDOM

Paul Allen

UNITED KINGDOM

Sara Pisani

King's College London

UNITED KINGDOM

David Lythgoe

King’s College London

UNITED KINGDOM

Dag Aarsland

King’s College London

UNITED KINGDOM

Mattia Veronese

King’s College London

UNITED KINGDOM

How do I reach out?

Meet Kite AI